PMID- 11798982
OWN - NLM
STAT- MEDLINE
DCOM- 20020314
LR  - 20191105
IS  - 1523-3774 (Print)
IS  - 1523-3774 (Linking)
VI  - 4
IP  - 1
DP  - 2002 Feb
TI  - Behcet's disease: immunopathologic and therapeutic aspects.
PG  - 47-54
AB  - Behcet's disease (BD) is a systemic inflammatory disease of unknown etiology. The 
      disease is strongly associated with the human leukocyte antigen (HLA) B51. BD has 
      a chronic course with periodic exacerbations and progressive deterioration. There 
      are no specific diagnostic laboratory tests, although recurrent oral ulceration 
      is an obligatory manifestation for diagnosis. The treatment, which includes 
      local, systemic, or surgical therapies, is based on the severity of the illness; 
      the most appropriate management requires a multidisciplinary approach. This paper 
      summarizes all aspects of BD with particular emphasis on the latest immunologic 
      and treatment aspects.
FAU - Meador, Robert
AU  - Meador R
AD  - Department of Rheumatology, Hospital of University of Pennsylvania, 3 Ravdin, 
      Suite G, 3400 Spruce Street, Philadelphia, PA, USA.
FAU - Ehrlich, George
AU  - Ehrlich G
FAU - Von Feldt, Joan M
AU  - Von Feldt JM
LA  - eng
PT  - Journal Article
PT  - Review
PL  - United States
TA  - Curr Rheumatol Rep
JT  - Current rheumatology reports
JID - 100888970
RN  - 0 (Adrenal Cortex Hormones)
RN  - 0 (Immunosuppressive Agents)
SB  - IM
MH  - Adrenal Cortex Hormones/administration & dosage
MH  - Adult
MH  - Age Distribution
MH  - Aged
MH  - Behcet Syndrome/*diagnosis/epidemiology/*therapy
MH  - Biopsy, Needle
MH  - Combined Modality Therapy
MH  - Female
MH  - Humans
MH  - Immunohistochemistry
MH  - Immunosuppressive Agents/administration & dosage
MH  - Incidence
MH  - Male
MH  - Middle Aged
MH  - Prognosis
MH  - Randomized Controlled Trials as Topic
MH  - Severity of Illness Index
MH  - Sex Distribution
RF  - 44
EDAT- 2002/01/19 10:00
MHDA- 2002/03/15 10:01
CRDT- 2002/01/19 10:00
PHST- 2002/01/19 10:00 [pubmed]
PHST- 2002/03/15 10:01 [medline]
PHST- 2002/01/19 10:00 [entrez]
AID - 10.1007/s11926-002-0023-z [doi]
PST - ppublish
SO  - Curr Rheumatol Rep. 2002 Feb;4(1):47-54. doi: 10.1007/s11926-002-0023-z.